Rationale and design of a large study to evaluate the renal and cardiovascular effects of an ACE inhibitor and vitamin E in high-risk patients with diabetes. The MICRO-HOPE Study. Microalbuminuria, cardiovascular, and renal outcomes. Heart Outcomes Prevention Evaluation.
第一作者:
H C,Gerstein
第一单位:
McMaster University, Hamilton, Ontario, Canada. gerstein@fhs.csu.mcmaster.ca
作者:
医学主题词
白蛋白尿(Albuminuria);血管紧张素转换酶抑制药(Angiotensin-Converting Enzyme Inhibitors);心血管疾病(Cardiovascular Diseases);糖尿病, 1型(Diabetes Mellitus, Type 1);糖尿病, 2型(Diabetes Mellitus, Type 2);糖尿病血管病变(Diabetic Angiopathies);糖尿病肾病(Diabetic Nephropathies);因素分析, 统计学(Factor Analysis, Statistical);人类(Humans);中年人(Middle Aged);安慰剂(Placebos);雷米普利(Ramipril);研究设计(Research Design);危险因素(Risk Factors);时间因素(Time Factors);维生素E(Vitamin E)
DOI
10.2337/diacare.19.11.1225
PMID
8908384
发布时间
2019-05-15
- 浏览16
Diabetes care
1225-8页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



